{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T10:04:34Z","timestamp":1779185074290,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T00:00:00Z","timestamp":1652400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jtocrr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JTO Clinical and Research Reports"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jtocrr.2022.100342","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T21:27:07Z","timestamp":1652909227000},"page":"100342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Percutaneous Image-Guided Biopsy for a Comprehensive Hybridization Capture-Based Next-Generation Sequencing in Primary Lung Cancer: Safety, Efficacy, and Predictors of Outcome"],"prefix":"10.1016","volume":"3","author":[{"given":"Ahmed","family":"Elsakka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena N.","family":"Petre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fourat","family":"Ridouani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Ghosn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Bott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan C.","family":"Husta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Arcila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etay","family":"Ziv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtocrr.2022.100342_bib1","first-page":"7","article-title":"Cancer statistics","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtocrr.2022.100342_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1093\/annonc\/mdz131","article-title":"Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001","volume":"30","author":"Shaw","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature17960","article-title":"Overcoming EGFR(T790M) and EGFR(C797S) resistance with mutant-selective allosteric inhibitors","volume":"534","author":"Jia","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jtocrr.2022.100342_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.semcancer.2019.09.015","article-title":"Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer","volume":"61","author":"Harrison","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib7","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1158\/1078-0432.CCR-14-2683","article-title":"Broad, hybrid capture-based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other genomic testing approaches","volume":"21","author":"Drilon","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2022.100342_bib8","doi-asserted-by":"crossref","first-page":"7113","DOI":"10.1158\/1078-0432.CCR-19-1700","article-title":"Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic approach","volume":"25","author":"Chang","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2022.100342_bib9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1373\/clinchem.2019.303644","article-title":"Biomarkers for predicting response to immunotherapy with immune checkpoint inhibitors in cancer patients","volume":"65","author":"Duffy","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/j.jtocrr.2022.100342_bib10","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1158\/1535-7163.MCT-17-0386","article-title":"Tumor mutational burden as an independent predictor of response to immunotherapy in diverse cancers","volume":"16","author":"Goodman","year":"2017","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtocrr.2022.100342_bib11","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/2159-8290.CD-16-1337","article-title":"Prospective comprehensive molecular characterization of lung adenocarcinomas for efficient patient matching to approved and emerging therapies","volume":"7","author":"Jordan","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtocrr.2022.100342_bib12","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2018.03.003","article-title":"Feasibility of endobronchial ultrasound transbronchial needle aspiration for massively parallel next-generation sequencing in thoracic cancer patients","volume":"119","author":"Turner","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100342_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2006.06.005","article-title":"Complex mutation patterns of epidermal growth factor receptor gene associated with variable responses to gefitinib treatment in patients with non-small cell lung cancer","volume":"53","author":"Hsieh","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100342_bib14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JTO.0b013e318287c91e","article-title":"Feasibility of image-guided transthoracic core-needle biopsy in the BATTLE lung trial","volume":"8","author":"Tam","year":"2013","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib15","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2214\/AJR.09.2858","article-title":"Core needle lung biopsy specimens: adequacy for EGFR and KRAS mutational analysis","volume":"194","author":"Solomon","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s10147-008-0772-4","article-title":"Accuracy of epidermal growth factor receptor gene mutation analysis by direct sequencing method based on small biopsy specimens from patients with non-small cell lung cancer: analysis of results in 19 patients","volume":"13","author":"Masago","year":"2008","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189651","article-title":"Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing","volume":"12","author":"Sabir","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jtocrr.2022.100342_bib18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/ajcp\/aqw043","article-title":"Test feasibility of next-generation sequencing assays in clinical mutation detection of small biopsy and fine needle aspiration specimens","volume":"145","author":"Zheng","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/03009734.2019.1607635","article-title":"Feasibility of genomic profiling with next-generation sequencing using specimens obtained by image-guided percutaneous needle biopsy","volume":"124","author":"Sone","year":"2019","journal-title":"Ups J Med Sci"},{"key":"10.1016\/j.jtocrr.2022.100342_bib20","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1200\/JCO.2015.66.0084","article-title":"The BATTLE-2 study: a biomarker-integrated targeted therapy study in previously treated patients with advanced non-small-cell lung cancer","volume":"34","author":"Papadimitrakopoulou","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib21","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncy.21338","article-title":"Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms","volume":"121","author":"Young","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/modpathol.2016.228","article-title":"Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies","volume":"30","author":"Roy-Chowdhuri","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/cncy.21597","article-title":"Factors affecting the success of next-generation sequencing in cytology specimens","volume":"123","author":"Roy-Chowdhuri","year":"2015","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib24","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jmoldx.2020.11.009","article-title":"Rapid EGFR mutation detection using the Idylla platform: single-institution experience of 1200 cases analyzed by an in-house developed pipeline and comparison with concurrent next-generation sequencing results","volume":"23","author":"Momeni-Boroujeni","year":"2021","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jtocrr.2022.100342_bib25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.5858\/arpa.2016-0108-RA","article-title":"Optimizing workflows and processing of cytologic samples for comprehensive analysis by next-generation sequencing: Memorial Sloan Kettering Cancer Center experience","volume":"140","author":"Tian","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jtocrr.2022.100342_bib26","first-page":"100077","article-title":"Ultrarapid EGFR mutation screening followed by comprehensive next-generation sequencing: a feasible, informative approach for lung carcinoma cytology specimens with a high success rate","volume":"1","author":"Arcila","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.jtocrr.2022.100342_bib27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1097\/JTO.0000000000000630","article-title":"The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification","volume":"10","author":"Travis","year":"2015","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1513\/AnnalsATS.201607-568BC","article-title":"What exactly is a centrally located lung tumor? Results of an online survey","volume":"14","author":"Casal","year":"2017","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jtocrr.2022.100342_bib29","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1148\/rg.346130092","article-title":"Update in the evaluation of the solitary pulmonary nodule","volume":"34","author":"Truong","year":"2014","journal-title":"RadioGraphics"},{"key":"10.1016\/j.jtocrr.2022.100342_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jvir.2012.02.012","article-title":"Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions","volume":"23","author":"Patel","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib31","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.jvir.2017.06.019","article-title":"Proposal of a new adverse event classification by the Society of Interventional Radiology Standards of Practice Committee [published correction appears in J Vasc Interv Radiol. 2018;29:146","volume":"28","author":"Khalilzadeh","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jnci\/djz245","article-title":"The molecular analysis for therapy choice (NCI-MATCH) trial: lessons for genomic trial design","volume":"112","author":"Flaherty","year":"2020","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtocrr.2022.100342_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2018.08.003","article-title":"Image-guided tumour biopsies in a prospective molecular triage study (MOSCATO-01): what are the real risks?Prud\u2019homme C","volume":"103","author":"Deschamps","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtocrr.2022.100342_bib34","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/ajcp\/aqv023","article-title":"Identification of factors affecting the success of next-generation sequencing testing in solid tumors","volume":"145","author":"Goswami","year":"2016","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib35","doi-asserted-by":"crossref","first-page":"154.e1","DOI":"10.1016\/j.crad.2020.08.010","article-title":"Image-guided biopsy in the age of personalised medicine: strategies for success and safety","volume":"76","author":"O\u2019Shea","year":"2021","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1148\/radiol.2016132230","article-title":"Genomic adequacy from solid tumor core needle biopsies of ex\u00a0vivo tissue and in\u00a0vivo lung masses: prospective study","volume":"282","author":"Jamshidi","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.jtocrr.2022.100342_bib37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00270-017-1861-4","article-title":"Determining the optimal number of core needle biopsy passes for molecular diagnostics","volume":"41","author":"Hoang","year":"2018","journal-title":"Cardiovasc Interv Radiol"},{"issue":"suppl 1","key":"10.1016\/j.jtocrr.2022.100342_bib38","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.4046\/trd.2020.0156","article-title":"Transthoracic needle biopsy: how to maximize diagnostic accuracy and minimize complications","volume":"83","author":"Chung","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"10.1016\/j.jtocrr.2022.100342_bib39","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1200\/JCO.2015.60.9818","article-title":"Solid predominant histologic subtype in resected stage i lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival","volume":"33","author":"Ujiie","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib40","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1093\/jnci\/djt166","article-title":"Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller","volume":"105","author":"Nitadori","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jtocrr.2022.100342_bib41","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the evolution of non\u2013small-cell lung cancer","volume":"376","author":"Jamal-Hanjani","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtocrr.2022.100342_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.athoracsur.2019.03.043","article-title":"Utility of core biopsy specimen to identify histologic subtype and predict outcome for lung adenocarcinoma","volume":"108","author":"Kim","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtocrr.2022.100342_bib43","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/s41467-021-27341-1","article-title":"The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics","volume":"12","author":"Tang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtocrr.2022.100342_bib44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1158\/1078-0432.CCR-20-3054","article-title":"Tumor mutational burden as a predictor of immunotherapy response: is more always better?","volume":"27","author":"Strickler","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtocrr.2022.100342_bib45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.cllc.2017.11.010","article-title":"Feasibility of endobronchial ultrasound-guided transbronchial needle aspiration cytology specimens for next generation sequencing in non\u2013small-cell lung cancer","volume":"19","author":"Stoy","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.jtocrr.2022.100342_bib46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.humpath.2015.12.025","article-title":"A\u00a0single EBUS-TBNA procedure can support a large panel of immunohistochemical stains, specific diagnostic subtyping, and multiple gene analyses in the majority of non-small cell lung cancer cases","volume":"51","author":"Rooper","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jtocrr.2022.100342_bib47","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1148\/radiol.11103506","article-title":"Rapid needle-out patient- rollover time after percutaneous CT-guided transthoracic biopsy of lung nodules: effect on pneumothorax rate","volume":"262","author":"O\u2019Neill","year":"2012","journal-title":"Radiology"}],"container-title":["JTO Clinical and Research Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666364322000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:37:27Z","timestamp":1762987047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666364322000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2666364322000662"],"URL":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100342","relation":{},"ISSN":["2666-3643"],"issn-type":[{"value":"2666-3643","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Percutaneous Image-Guided Biopsy for a Comprehensive Hybridization Capture-Based Next-Generation Sequencing in Primary Lung Cancer: Safety, Efficacy, and Predictors of Outcome","name":"articletitle","label":"Article Title"},{"value":"JTO Clinical and Research Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtocrr.2022.100342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the International Association for the Study of Lung Cancer.","name":"copyright","label":"Copyright"}],"article-number":"100342"}}